GlaxoSmithKline PLC (NYSE:GSK)
| 39.00 BATS BZX Real-Time Price As of 11:28am ET |  +0.07 / +0.18%Today’s Change | 33.26 Today|||52-Week Range 42.68 | +5.98% Year-to-Date |
Latest GSK News | Press Releases
| Glaxo's (GSK) Nucala Gets CHMP Nod for 3 Diseases in Europe 8:12am / Zacks.com - Paid Partner Content | HOOKIPA (HOOK), Merck Collaborate to Treat Head & Neck Cancers Sep 16 / Zacks.com - Paid Partner Content |
| Here's Why Moderna's Stock Could Crash Before the End of 2021 Sep 19 / MotleyFool.com - Paid Partner Content | Theravance (TBPH) to Cut Workforce, Hypotension Study Fails Sep 16 / Zacks.com - Paid Partner Content |
| 5 COVID Vaccine Stocks With Late-Stage Candidates You'll Want to Watch Sep 18 / MotleyFool.com - Paid Partner Content | Cigarette group takes control of asthma inhaler maker Sep 16 / CNN.com - Paid Partner Content |
| Lilly (LLY) Gets FDA Nod for Expanded Use of COVID Cocktail Sep 17 / Zacks.com - Paid Partner Content | 3 Stocks I Bought That Could Produce 10X Returns Sep 15 / MotleyFool.com - Paid Partner Content |
| Regeneron, Lilly Get New COVID Drug Deals From Government Sep 16 / Zacks.com - Paid Partner Content | 4 Top Healthcare Stocks to Buy in September Sep 14 / StockNews.com - Paid Partner Content |
Today’s Trading
| Previous close | 38.93 |
| Today’s open | 38.35 |
| Day’s range | 38.32 - 39.05 |
| Volume | 1,592,521 |
| Average volume (3 months) | 3,949,301 |
| Market cap | $100.4B |
Data as of 11:28am ET, 09/20/2021
Growth & Valuation
| Earnings growth (last year) | +23.68% |
| Earnings growth (this year) | -63.61% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | +1.55% |
| P/E ratio | 16.5 |
| Price/Sales | 2.12 |
| Price/Book | 4.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZTSZoetis Inc | +1.14 | +0.57% |
| ---- | ||
| SNYSanofi | -0.16 | -0.33% |
| REGNRegeneron Pharmaceut... | -2.27 | -0.35% |
Data as of 11:29am ET, 09/20/2021
Financials
| Next reporting date | October 27, 2021 |
| EPS forecast (this quarter) | $0.79 |
| Annual revenue (last year) | $43.7B |
| Annual profit (last year) | $7.4B |
| Net profit margin | 16.86% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Middlesex, Greater London |
Forecasts
